Latham & Watkins , Orrick, Schoenherr and EY advised Cerba HealthCare on the deal while Chiomenti, Wolf Theiss and Deloitte advised Investindustrial. Paul Hastings advised EQT...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised the underwriters, while Latham & Watkins represented Rapid Micro Biosystems, Inc. in the offering. Rapid Micro Biosystems, Inc. (Nasdaq: RPID), an innovative life sciences...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Vedanta Biosciences on the deal. Vedanta Biosciences announced the closing of a $68 million Series D financing. The round was led by affiliates of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Assurly on the deal. Assurly announced its 6 million financing round from a network of English entrepreneurs, Cleverton Ventures, as well as French business...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Roxborough Group on the deal. Roxborough Group announced the final closing of its latest value-add fund, Roxborough Fund III, L.P. with capital commitments of...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Rare Whisky Holdings on the deal. Rare Whisky Holdings announced its agreement to acquire a 49% stake in Whisky Hammer and Still Spirit. Rare...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Blend on the deal while Goodwin Procter represented the underwriters. Blend Labs, Inc. announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Captify Technologies on the deal. Captify, the Search Intelligence Platform for the open web, announced that SFW Capital Partners, a leading US-based private...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised TA Associates and CCRM Fertility on the deal. Unified Women’s Healthcare, a leading practice management platform in women’s healthcare backed by Altas Partners,...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Repligen Corporation on the deal. Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced the acquisition of Polymem S.A., a leading...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Intellia Therapeutics on the deal. Intellia Therapeutics, Inc. (Nasdaq: NTLA) announced its $690 million underwritten public offering on the heels of releasing the first-ever...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...
You must be a Standard 1 Year member to access this content.
